发明名称 4-HETEROCYCLYLSULFONEAMIDYL-6-METHOXY-5-(2-METHOXYPHENOXY)-2-PYRIDYLPYRIMIDINE DERIVATIVES AND PHARMACEUTICAL COMPOSITION
摘要 FIELD: organic chemistry, medicine, pharmacy. SUBSTANCE: invention relates to 4-heteriocyclylsolfoneamidyl-6-methoxy-5-(2-methoxyphenoxy)-2-pyridylpyrimidine derivatives of the formula (I) where R1 means heterocyclic fragment taken among pyridyl and thiazolyl where this heterocyclic fragment is substituted optionally with (lower) alkyl or (lower) alkenyl and to their pharmaceutically acceptable salts. These compounds are inhibitors of endothelin receptors and therefore they can be used for treatment of patients with diseases associated with anomalous vascular tonus and endothelial dysfunction. EFFECT: valuable medicinal properties of compounds. 9 cl, 3 tbl
申请公布号 RU2201928(C1) 申请公布日期 2003.04.10
申请号 RU20010126348 申请日期 2000.02.28
申请人 F.KHOFFMANN-LJA ROSH AG 发明人 BREU FOL'KER;KOASSOLO FILIPP;NEHDAR VERNER;RUKS SEBAST'EN;VAJSS PETER
分类号 A61K31/505;A61P9/00;C07D401/14;C07D417/14;(IPC1-7):C07D401/14 主分类号 A61K31/505
代理机构 代理人
主权项
地址